HJ445A
| Catalog Number | Pack Size | List Price* | Quantity | |
|---|---|---|---|---|
| HY-163084-1MG | 1 mg | 204,00 | Add | |
| HY-163084-5MG | 5 mg | 494,00 | Add | |
| HY-163084-10MG | 10 mg | 734,00 | Add | |
| HY-163084-25MG | 25 mg | 1'457,00 | Add | |
| HY-163084-50MG | 50 mg | 2'178,00 | Add | |
| HY-163084-100MG | 100 mg | 3'262,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
HJ445A is a potent MYOF inhibitor and binds to the MYOF-C2D domain with a KD of 0.17 μM. HJ445A potently repressed the proliferation of gastric cancer cells with IC50 values of 0.16 and 0.14 μM in MGC803 and MKN45, respectively. HJ445A demonstrates superior antitumor efficacy in vivo and can be used for cancer research[1].
| Category | Biochemicals |
| Supplier | MedChem Express |
| Regulatory Status | RUO |
| Research Field | Cancer, s |
| Format | Solubility: DMSO : 100 mg/mL (ultrasonic) |
| Grade | Clinical information: No Development Reported |
| Purity | 98.31% |
| Molecular Formula | C24H27N7O2 |
| Molecular Weight | 445.52 |
| Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
| Tech. Data Sheet | View datasheet |
| Link To Supplier | http://www.medchemexpress.com |
| Shipping Details | Room Temperature |
| Material Safety Data Sheet | Download PDF |
